MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Solution

国药准字H20223942

December 30, 2022

Drug Information

吸入用硫酸沙丁胺醇溶液

吸入制剂

2.5ml:5mg(以沙丁胺醇计)

化学药品

December 30, 2022

Company Information

Applicant Company

上海市宝山区园康路300号2幢1楼

Manufacturing Company

上海市宝山区抚远路2151号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用硫酸沙丁胺醇溶液 - NMPA 批准文号 | MedPath